文献速递肿瘤 PET/CT

68Ga-FAPI-04与18F-FDG PET/CT在克罗恩病评估中的头对头比较:一项前瞻性先导研究

Head-to-Head Comparison of 68 Ga-FAPI-04 and 18 F-FDG PET/CT for the Assessment of Crohn's Disease : A Prospective Pilot Study.
PubMed 文献 · Clin Nucl Med · 2025-03-31

该前瞻性先导研究纳入17例新诊断或复发克罗恩病患者,均行68Ga-FAPI-04与18F-FDG PET/CT。68Ga-FAPI-04 PET/CT诊断性能优于18F-FDG PET/CT(AUC 0.92 vs 0.87,P=0.043),且两种示踪剂在狭窄/瘘管病变的SUVmax均显著高于非狭窄/瘘管病变。

要点

  • 68Ga-FAPI-04 PET/CT诊断克罗恩病的AUC为0.92,优于18F-FDG的0.87(P=0.043)。
  • 68Ga-FAPI与18F-FDG在狭窄/瘘管病变的SUVmax均显著高于非狭窄/瘘管病变。
  • 68Ga-FAPI-04 PET/CT的TIU FAPI和MIV FAPI与高敏C反应蛋白及SES-CD显著相关。

核心结论

  • 68Ga-FAPI-04 PET/CT在克罗恩病中的诊断性能优于18F-FDG PET/CT。

研究设计与样本

  • 前瞻性队列研究,纳入新诊断或复发克罗恩病患者,所有患者均接受68Ga-FAPI-04和18F-FDG PET/CT检查,比较两种PET/CT模态的诊断性能及摄取值,并分析PET半定量参数与临床生物标志物的相关性。
  • 共纳入17例参与者(13例男性,4例女性,年龄32.3±15.9岁)。

主要发现

  • 68Ga-FAPI-04与18F-FDG PET/CT检测克罗恩病灶的灵敏度分别为90.0%和85.0%,特异度分别为93.0%和88.4%。
  • ROC曲线分析中,68Ga-FAPI-04 PET/CT的AUC为0.92(95%CI:0.83-0.97,P<0.001),18F-FDG PET/CT的AUC为0.87(95%CI:0.78-0.93,P<0.001),两者比较P=0.043。
  • 狭窄/瘘管病变中68Ga-FAPI的SUVmax为10.9±6.7,显著高于非狭窄/瘘管病变的5.0±3.5(P=0.0002);18F-FDG的SUVmax为9.5±4.9,显著高于非狭窄/瘘管病变的5.3±1.8(P=0.0016)。
  • 68Ga-FAPI-04 PET/CT的TIU FAPI和MIV FAPI与高敏C反应蛋白及克罗恩病简化内镜评分(SES-CD)显著相关(P<0.05)。
  • 18F-FDG PET/CT的TIU FDG和MIV FDG也与SES-CD显著相关(P<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Crohn disease is a chronic granulomatous inflammatory disease of gastrointestinal tract. Previous studies showed Crohn disease strictures overexpress fibroblast activation protein and had active 68 Ga-FAPI-04 uptake. Our study was to compare the diagnostic performance of 68 Ga-FAPI-04 and 18 F-FDG PET/CT in Crohn disease. PATIENTS AND METHODS: This is a prospective cohort study recruiting patients with newly diagnosed or relapsed Crohn disease. All the patients underwent 68 Ga-FAPI-04 and 18 F-FDG PET/CT. The diagnostic performance of the 2 PET/CT modalities and their uptake values were compared. The correlation of PET semiquantitative parameters [metabolic intestinal volume (MIV FDG and MIV FAPI ), total intestinal uptake (TIU FDG and TIU FAPI )] with clinical biomarkers were also analyzed. RESULTS: Seventeen participants (13 men and 4 women, age 32.3 ± 15.9 y) were recruited. The sensitivity of 68 Ga-FAPI-04 and 18 F-FDG PET/CT in detecting Crohn lesions were 90.0% and 85.0%, and the specificities were 93.0% and 88.4%, respectively. In receiver operating characteristic curve analysis, 68 Ga-FAPI-04 PET/CT [area under the curve = 0.92 (95% CI: 0.83-0.97), P < 0.001] showed better diagnostic performance compared with 18 F-FDG PET/CT [area under the curve = 0.87 (95% CI: 0.78-0.93), P < 0.001; P = 0.043]. The SUVmax of 68 Ga-FAPI and 18 F-FDG in stricture/fistula lesions were significantly higher than those in non-stricture/fistula lesions ( 68 Ga-FAPI, 10.9 ± 6.7 vs 5.0 ± 3.5, P = 0.0002; 18 F-FDG, 9.5 ± 4.9 vs 5.3 ± 1.8, P = 0.0016). TIU FAPI and MIV FAPI of 68 Ga-FAPI-04 PET/CT were significantly correlated with high sensitivity C-reactive protein and simple endoscopic score for Crohn disease ( P < 0.05). TIU FDG and MIV FDG of 18 F-FDG PET/CT were also correlated with simple endoscopic scores for Crohn disease ( P < 0.05). CONCLUSIONS: 68 Ga-FAPI-04 PET/CT showed better diagnostic performance than 18 F-FDG PET/CT in Crohn disease.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Pan Q, Xu H, Liu S, et al. Head-to-Head Comparison of 68 Ga-FAPI-04 and 18 F-FDG PET/CT for the Assessment of Crohn's Disease : A Prospective Pilot Study. Clin Nucl Med. 2025. PMID: 40173312. doi:10.1097/RLU.0000000000005815

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。